Study guide

5.2 Portable Ventilators & Modes (PC, VC, PRVC, High Frequency)

Neonatal Pediatric Transport C-NPT

Track your progress as you read

Finished sections get a check mark.

1 Introduction: The C-NPT Exam

About the C-NPT Exam: 2026 Format, Eligibility & Content Outline

2 Chapter 1: Transport Systems, Regulatory Framework & Legal Issues

1.1 Transport System Architecture, Accreditation (CAMTS) & Dispatch Triage 1.2 Regulatory & Legal Mandates: EMTALA, HIPAA, Consent & Documentation 1.3 Medical Direction, Scope of Practice & Ethical Considerations

3 Chapter 2: Safety, Communication, Crew Resource Management & Transport Environment

2.1 Crew Resource Management (CRM), Situational Awareness & Sterile Cockpit 2.2 Aircraft & Ground Ambulance Operations, Landing Zones & Vehicle Dynamics 2.3 Environmental Hazards, Weather Minimums & In-Flight Emergency Procedures 2.4 Communication in Transport: Peer Handoffs, Age-Appropriate Care, Families & Crew Stressors 2.5 Infection Control, PPE, Scene Safety & Disaster/Evacuation Planning

4 Chapter 3: Flight Physiology & Environmental Stressors

3.1 Physical Gas Laws & Transport Implications (Boyle, Dalton, Charles, Henry, Graham) 3.2 Altitude Hypoxia, Barometric Pressure Changes & Dysbarism 3.3 Acceleration Forces (G-forces), Vibration & Acoustic Stress in Transit 3.4 Thermoregulation Physics & Neutral Thermal Environment in Transit

5 Chapter 4: Invasive Procedures & Transport Monitoring

4.1 Advanced Airway Management & Endotracheal Intubation in Transit 4.2 Pleural Decompression (Needle Thoracostomy & Chest Tube Management) 4.3 Vascular Access: Umbilical Lines (UAC/UVC), Intraosseous (IO) & Arterial Lines

6 Chapter 5: Transport Equipment, Respiratory Physiology & Mechanical Ventilation

5.1 Transport Incubators (Isolettes), Thermal Control & Electrical/Gas Power Systems 5.2 Portable Ventilators & Modes (PC, VC, PRVC, High Frequency) 5.3 Gas Cylinder Duration Calculations, Oxygen Delivery & Inhaled Nitric Oxide (iNO) 5.4 Respiratory Physiology: Acid-Base Balance, Oxygenation, Lung Mechanics & Troubleshooting

7 Chapter 6: Transport Pharmacology, Resuscitation, Fluids & Electrolytes

6.1 Vasoactive Infusions & Inotropes (Epinephrine, Dopamine, Dobutamine, Milrinone) 6.2 Sedation, Analgesia & Neuromuscular Blockade in Transport 6.3 Prostaglandin E1 (Alprostadil) & Surfactant Replacement Therapy 6.4 Resuscitation Protocols (NRP, PALS) & Shock Fluid Resuscitation 6.5 Antimicrobial Pharmacology in Neonatal & Pediatric Transport 6.6 Post-Resuscitation Care, Defibrillation & Cardioversion in Transit, ECMO Indications & the Transport-vs-Stay Decision 6.7 Fluid & Electrolyte Therapy Across the Ages: Maintenance, Dehydration, Fluid Overload & Electrolyte Emergencies

8 Chapter 7: Neonatal Respiratory Pathologies & Management

7.1 Respiratory Distress Syndrome (RDS) & Surfactant Deficiency 7.2 Meconium Aspiration Syndrome (MAS) & Persistent Pulmonary Hypertension (PPHN) 7.3 Transient Tachypnea (TTN), Neonatal Pneumothorax & Congenital Diaphragmatic Hernia (CDH) 7.4 Neonatal Upper Airway Anomalies, Aspiration, Pneumonia, Chronic Lung Disease & Respiratory Failure

9 Chapter 8: Neonatal Cardiovascular Critical Care

8.1 Ductal-Dependent Cyanotic Congenital Heart Defects (TGA, TOF, Tricuspid Atresia) 8.2 Ductal-Dependent Systemic Blood Flow Lesions (HLHS, Coarctation, Interrupted Arch) 8.3 Neonatal Arrhythmias, Cardiogenic Shock & Post-Resuscitation Care 8.4 Acyanotic Congenital Heart Lesions, Patent Ductus Arteriosus, Obstructed TAPVR & Neonatal Heart Failure

10 Chapter 9: Neonatal Neurological & Metabolic Crises

9.1 Hypoxic-Ischemic Encephalopathy (HIE) & Passive/Active Therapeutic Hypothermia 9.2 Neonatal Seizures & Intraventricular Hemorrhage (IVH) 9.3 Neonatal Hypoglycemia, Electrolyte Derangements & Hyperbilirubinemia 9.4 Subgaleal Hemorrhage, Neonatal Sepsis & Meningitis, and Perinatal Substance Exposure (NOWS)

11 Chapter 10: Neonatal Surgical Emergencies, Neural Tube Defects & ELBW Care

10.1 Abdominal Wall Defects (Gastroschisis vs. Omphalocele) & TEF/Esophageal Atresia 10.2 Necrotizing Enterocolitis (NEC), Malrotation with Volvulus & Intestinal Obstruction 10.3 Care of the Extremely Low Birth Weight (ELBW) Infant (<1000g) in Transit 10.4 Neural Tube Defects: Myelomeningocele, Encephalocele & Transport of the Newborn With an Open Spinal Defect

12 Chapter 11: Pediatric Respiratory Emergencies

11.1 Acute Upper Airway Obstruction (Croup, Epiglottitis, Bacterial Tracheitis, Foreign Body) 11.2 Lower Airway Crises: Status Asthmaticus & Severe Bronchiolitis 11.3 Pediatric Acute Respiratory Distress Syndrome (PARDS) & Severe Pneumonia

13 Chapter 12: Pediatric Shock & Cardiovascular Crises

12.1 Pathophysiology & Transport Management of Pediatric Septic Shock 12.2 Hypovolemic, Cardiogenic & Anaphylactic Shock in Children 12.3 Pediatric Cardiac Emergencies: SVT, Ventricular Arrhythmias & Myocarditis 12.4 Pediatric Cardiovascular Crises: Palliated Congenital Heart Disease, Pulmonary Hypertensive Crisis, Pericarditis & Tamponade, Hypertensive Emergency & Anterior Mediastinal Mass

14 Chapter 13: Pediatric Neurological Emergencies & Trauma

13.1 Status Epilepticus, Altered Mental Status & Meningitis/Encephalitis 13.2 Pediatric Traumatic Brain Injury (TBI) & Increased Intracranial Pressure (ICP) 13.3 Blunt/Penetrating Trauma, Spinal Motion Restriction & Thermal Burns 13.4 Non-Accidental Trauma, Smoke Inhalation (Carbon Monoxide & Cyanide) & Heat Illness

15 Chapter 14: Pediatric Toxicological, Environmental & Endocrine Emergencies

14.1 Common Pediatric Toxic Ingestions, Poisonings & Antidotes 14.2 Diabetic Ketoacidosis (DKA) & Environmental Emergencies (Submersion, Hypothermia) 14.3 Button Battery & Foreign-Body Ingestions, Bites & Envenomations, and Hazardous-Material Exposures

16 Chapter 15: Pediatric Metabolic & Hematologic Emergencies

15.1 Anemia, Sickle Cell Disease, Coagulopathies & Blood Product Administration 15.2 Oncologic Emergencies, Acute Kidney Injury & Pediatric Electrolyte Crises

5.2 Portable Ventilators & Modes (PC, VC, PRVC, High Frequency)

Key Takeaways Explain This Topic AI

Neonatal lung mechanics are defined by high chest wall compliance and low lung compliance, yielding ultra-short time constants (0.05–0.15 s) that mandate rapid respiratory rates (40–60 bpm) and short inspiratory times (0.25–0.40 s).

Target tidal volumes must be strictly calibrated: 4–6 mL/kg for preterm infants with respiratory distress syndrome (RDS) to prevent volutrauma and hypocarbic cerebral ischemia, and 6–8 mL/kg for normal pediatric lungs.

Pressure Regulated Volume Control (PRVC) automatically modulates peak inspiratory pressure breath-by-breath to deliver a set tidal volume at the lowest possible pressure, mitigating volutrauma during dynamic compliance shifts following surfactant administration.

In High-Frequency Oscillatory Ventilation (HFOV), carbon dioxide elimination is governed by DCO2 = Vt^2 * f; lowering frequency increases stroke volume displacement, paradoxically increasing CO2 clearance.

High-Frequency Jet Ventilation (HFJV) delivers ultra-short jet pulses with passive exhalation at lower peak alveolar pressures, making it the preferred high-frequency mode for pulmonary interstitial emphysema (PIE) and active air leaks.

Last updated: September 2026

Portable Ventilators & Modes (PC, VC, PRVC, High Frequency)

Mechanical ventilation in neonatal and pediatric transport requires deep comprehension of cardiopulmonary physiology, respiratory mechanics, and specialized ventilator technologies. The transport clinician must deliver lung-protective ventilation while navigating vehicle acceleration forces, cabin altitude pressure swings, and motion-induced monitoring artifacts.

Dedicated Transport Ventilators

Unlike bulky intensive care unit ventilators, transport ventilators must be rugged, lightweight, energy-efficient, and capable of operating independently of hospital piped gases and AC power:

Hamilton T1 / MR1: Microprocessor-controlled with an integrated high-performance turbine that generates inspiratory flow without requiring high-pressure medical air cylinders. Features advanced neonatal software capable of delivering tidal volumes down to 2 mL, proximal flow sensing, active leak compensation (nCPAP, non-invasive modes), and closed-loop ventilation modes (ASV/INTELLiVENT).

Crossvent 2i+ / 3+: Pneumatically driven and electronically controlled, time-cycled, and pressure-limited. It relies entirely on high-pressure cylinder gas (driving gas consumption adds 3 to 10 L/min to tank depletion). Highly durable with minimal moving parts, but lacks advanced closed-loop volume targeting.

CareFusion / Pulmonetic ReVel & Dräger Oxylog 3000+: Versatile turbine or pneumatically driven ventilators widely used for pediatric and adult transport, capable of pressure-support and SIMV modes down to early pediatric weight thresholds.

Neonatal & Pediatric Respiratory Mechanics: Time Constants

Effective ventilation depends on the mechanical properties of the respiratory system:

Chest Wall vs. Lung Compliance: Preterm neonates have a remarkably compliant, cartilaginous thoracic cage that provides minimal outward elastic recoil, rendering them vulnerable to severe sternal retractions. Conversely, their lungs in RDS are stiff, non-compliant, and surfactant-deficient.

The Time Constant Formula: The respiratory time constant ( τ \tau τ ) represents the time required for alveolar pressure and volume to reach 63% of equilibrium during inspiration or expiration: τ = C r s × R a w \tau = C_{rs} \times R_{aw} τ = C rs ​ × R a w ​ where C r s C_{rs} C rs ​ is total respiratory compliance and R a w R_{aw} R a w ​ is airway resistance.

Equilibration Kinetics:

  • 1 τ = 63 % 1\tau = 63\% 1 τ = 63% equilibration
  • 2 τ = 86 % 2\tau = 86\% 2 τ = 86% equilibration
  • 3 τ = 95 % 3\tau = 95\% 3 τ = 95% equilibration
  • 5 τ = 99 % 5\tau = 99\% 5 τ = 99% complete alveolar filling or emptying

Physiological Consequences: In normal neonates, τ ≈ 0.10 − 0.15 \tau \approx 0.10 - 0.15 τ ≈ 0.10 − 0.15 seconds. In preterm RDS with low compliance, the time constant drops to 0.05 to 0.10 seconds . Therefore, complete alveolar filling ( 3 τ − 5 τ 3\tau - 5\tau 3 τ − 5 τ ) requires an inspiratory time ( T i Ti T i ) of only 0.25 to 0.40 seconds !

Setting an excessively long T i Ti T i (>0.50 s) in stiff lungs creates a prolonged inspiratory plateau with zero airflow, impeding venous return, reducing cardiac output, and increasing the risk of barotrauma.

Conversely, pediatric patients with obstructive lower airway disease (asthma, bronchiolitis) have high resistance, prolonging τ \tau τ to >0.4–0.6 seconds. This requires a prolonged expiratory time ( T e Te T e ) to prevent incomplete exhalation and air trapping (auto-PEEP).

Core Ventilation Modes: PC vs. VC vs. PRVC

Mechanical Parameter Pressure Control (PC-CMV / SIMV) Volume Control (VC-CMV) Pressure Regulated Volume Control (PRVC / Volume Guarantee)

Control Variable Inspiratory Pressure (PIP) Tidal Volume ( V t V_t V t ​ ) Tidal Volume ( V t V_t V t ​ ) with pressure limits

Flow Waveform Decelerating exponential flow Constant square or ramp flow Decelerating flow

Delivered Volume Variable; depends on C r s C_{rs} C rs ​ and R a w R_{aw} R a w ​ Constant; volume guaranteed Target volume guaranteed breath-by-breath

Primary Strength Prevents excessive alveolar pressure Ensures stable minute ventilation Auto-titrates PIP as compliance improves

Primary Risk Volutrauma/hypocarbia if compliance rises High peak pressures if compliance falls; leaks cause hypoventilation Pressure swings during active patient crying

Pressure Regulated Volume Control (PRVC) in Transit

In PRVC (known as Volume Guarantee on neonatal platforms), the ventilator delivers a test breath to measure dynamic compliance. It then adjusts the peak inspiratory pressure step-by-step (by ± 1 − 3 cmH 2 O \pm 1 - 3\text{ cmH}_2\text{O} ± 1 − 3 cmH 2 ​ O per breath) to deliver the set target tidal volume at the lowest possible airway pressure.

Surfactant Administration Protection: When exogenous surfactant is administered in transit, lung compliance can improve by 200% within minutes. Under fixed Pressure Control, unchanged PIP would result in massive, destructive tidal volumes and severe hypocarbia ( P a C O 2 < 30 mmHg PaCO_2 < 30\text{ mmHg} P a C O 2 ​ < 30 mmHg ), triggering cerebral vasoconstriction and periventricular leukomalacia (PVL). Under PRVC, the ventilator senses improving compliance and automatically drops PIP, protecting the brain and capillary endothelium.

Tidal Volume Targets & PEEP Optimization

Neonates with RDS / Preterm: Target 4 to 6 mL/kg . Overventilation (>6 mL/kg) causes volutrauma and biotrauma. Underventilation (<4 mL/kg) results in microatelectasis and progressive hypoxia.

Normal Pediatric Lungs: Target 6 to 8 mL/kg .

Severe Pediatric ARDS (PARDS): Target 3 to 6 mL/kg using permissive hypercapnia ( p H ≥ 7.25 pH \ge 7.25 p H ≥ 7.25 ).

PEEP Optimization: A baseline PEEP of about 5 to 8 cmH2O is typical in neonatal transport. Surfactant-deficient alveoli collapse at end-expiration. Adequate PEEP preserves Functional Residual Capacity (FRC), splints microairways open, prevents end-expiratory shearing injury (atelectrauma), and optimizes the surface area for diffusion.

High-Frequency Ventilation in Transport: HFOV vs. HFJV

When conventional mechanical ventilation fails to achieve oxygenation ( F i O 2 > 0.80 FiO_2 > 0.80 F i O 2 ​ > 0.80 , high PIP) or in the presence of severe air leak syndromes, specialized transport teams deploy High-Frequency Ventilation:

High-Frequency Oscillatory Ventilation (HFOV)

Mechanics: Active inspiration and active expiration driven by an electromagnetic diaphragm or reciprocating piston. Delivers tidal volumes smaller than anatomical dead space (1–2 mL/kg) at frequencies of 8 to 15 Hertz ( 1 Hz = 60 breaths/min 1\text{ Hz} = 60\text{ breaths/min} 1 Hz = 60 breaths/min ; 10 Hz = 600 bpm 10\text{ Hz} = 600\text{ bpm} 10 Hz = 600 bpm ).

Oxygenation: Controlled by Mean Airway Pressure (MAP / P a w P_{aw} P a w ​ ) . MAP is adjusted 1–2 cmH2O above conventional MAP to achieve continuous alveolar recruitment on the open-lung hysteresis curve.

Ventilation / C O 2 CO_2 C O 2 ​ Clearance: Controlled by Amplitude ( Δ P \Delta P Δ P ) and Frequency ( f f f ) . DCO 2 = V t 2 × f \text{DCO}_2 = V_t^2 \times f DCO 2 ​ = V t 2 ​ × f

The Inverse Frequency Rule: In conventional ventilation, raising respiratory rate increases C O 2 CO_2 C O 2 ​ clearance. In HFOV, because tidal volume is squared in the gas transport equation, decreasing frequency (Hz) allows the piston longer travel time, producing a larger stroke tidal volume and substantially increasing C O 2 CO_2 C O 2 ​ elimination !

High-Frequency Jet Ventilation (HFJV)

Mechanics: Delivers ultra-short, high-velocity jet pulses (usually 4 to 11 Hz; 240–660 bpm) into the airway via a specialized nozzle adapter, with passive exhalation . Operates in tandem with a conventional ventilator that supplies baseline PEEP and low-rate sigh breaths.

Clinical Superiority in Air Leaks: HFJV produces lower peak alveolar pressures, making it the definitive transport modality for pulmonary interstitial emphysema (PIE), active pneumothoraces, and bronchopleural fistulas .

Monitoring Lung Mechanics En Route

Peak Inspiratory Pressure (PIP) vs. Plateau Pressure ( P p l a t P_{plat} P pl a t ​ ): PIP reflects both dynamic airway resistance and static alveolar elastance. P p l a t P_{plat} P pl a t ​ (measured via inspiratory pause) reflects alveolar distension. A widening gap ( P I P − P p l a t PIP - P_{plat} P I P − P pl a t ​ ) signals acute airway obstruction (ETT kinking, bronchospasm, secretion plugging).

Auto-PEEP (Intrinsic PEEP): Detected when expiratory flow fails to reach the zero baseline before the subsequent breath initiates. Common in asthma and bronchiolitis. Dynamic hyperinflation increases intrathoracic pressure, compresses the vena cava, drops preload, and precipitates circulatory collapse. Management requires decreasing respiratory rate, shortening T i Ti T i , and increasing T e Te T e .

Realistic Transport Scenario: RDS Surfactant Stabilization

A transport team arrives at a community hospital to transport a 28-week infant (weight 1.1 kg) in severe RDS on a conventional ventilator: PC-SIMV, PIP 26, PEEP 5, RR 50, T i Ti T i 0.35 s, F i O 2 FiO_2 F i O 2 ​ 0.75, with an arterial blood gas showing pH 7.21, P a C O 2 PaCO_2 P a C O 2 ​ 64, P a O 2 PaO_2 P a O 2 ​ 52. The team transitions the infant to a transport ventilator using PRVC (Volume Guarantee) with a target tidal volume of 4.5 mL/kg (5.0 mL total), PEEP 6 cmH2O, and RR 55 bpm. The team administers exogenous surfactant en route. Within 20 minutes, lung compliance improves dramatically. Under PRVC, the ventilator automatically steps PIP down from 26 to 15 cmH2O while maintaining target V t V_t V t ​ , preventing barotrauma and stabilizing P a C O 2 PaCO_2 P a C O 2 ​ at 46 mmHg upon arrival at the tertiary center.

Clinical Pearls for Transport Ventilation

Tip

The HFOV Paradox: To blow off more C O 2 CO_2 C O 2 ​ on an oscillator, do not increase the Hertz. Turn the frequency down . Lower Hertz gives the diaphragm longer stroke time, increasing tidal volume squared.

Important

Surfactant Compliance Surge: If transporting an infant on pure Pressure Control after surfactant, you must manually decrease PIP as compliance improves. Failing to do so delivers massive tidal volumes that burst alveoli and cause hypocarbic cerebral vasoconstriction.

Note

Short Time Constants: Stiff neonatal lungs fill in 0.25 to 0.35 seconds. Giving an inspiratory time of 0.6 seconds in severe RDS does not recruit lung tissue; it merely impairs venous return and causes hypotension.

Loading diagram... Neonatal Time Constant & Transport Ventilation Mode Selection Pathway